The Joint (JYNT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on The Joint (JYNT) is Neutral.

The composite score behind that read is -0.18, weighing +0.06 of bullish evidence against -0.37 bearish.

The Joint last closed at $7.04, -1.12% on the session.

Against the IVW growth benchmark the position is -1.92% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for JYNT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks The Joint in the 15th percentile on valuation and the 66th percentile on return on equity, where 100 is best.

The Joint is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $100.70M.

StockMap tracks The Joint as the 73rd largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite The Joint ranks 80th of 85 in the group, against a group median of +0.00.